Cytomos, an Edinburgh-based life science company that has developed a proprietary new approach to analysing cells, has secured £1.6m funding to progress the development and qualification of its novel cell analysis platform, Cytomos Dielectric Spectroscopy (CDS). The fundraising round by Cytomos was led by existing investor Archangels with participation from Scottish Enterprise and Old College Capital. Cytomos […]
CARLSBAD, Calif. — ChromaCode, a genomics multiplexing platform company developing accessible and affordable solutions for laboratories, patients and physicians, today announced a strategic investment from corporate venture capital fund Shimadzu Future Innovation Fund L.P., with general partner Global Brain Corporation. This funding will support ChromaCode’s continued development of its HDPCR technology to deliver high quality, faster, […]
On May 19, Shimadzu Corporation has invested in ChromaCode Inc. (ChromaCode), a startup with technology to expand genetic testing, through its corporate venture capital (CVC) fund, Shimadzu Future Innovation Fund L.P. (Shimadzu FIF). This is Shimadzu FIF’s first investment. ChromaCode is a startup that expands the number of target genes available in existing PCR with […]
SAN DIEGO — Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced the closing of its private placement of redeemable convertible preferred stock and warrants resulting in initial gross proceeds of $28.0 million to Telesis Bio. The warrants issued in the private placement will […]
Up to an Additional $46.2 Million Available Through Warrant Exercise Led by Novalis LifeSciences LLC with participation from Northpond Ventures, M-185 Corporation and BroadOak Capital Partners SAN DIEGO — Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced it has signed a securities purchase […]
Instrumentation company shortens development and discovery of new materials Exum Instruments is an extremely innovative hard tech company. We’re particularly excited about Massbox’s potential impact in the energy tech space and on Exum’s Tulsa manufacturing capacity.” — James Spann, Founder & General Partner, Boyd Street Ventures NORMAN, OK, UNITED STATES — Boyd Street Ventures announced that it […]
ASCEND by BenchSci harnesses proprietary text and image-based machine learning models, empowering scientists to dramatically improve the speed and success of research at any stage of pre-clinical drug development TORONTO, CANADA – BenchSci, a world leader in AI solutions for preclinical life sciences research and development (R&D), today announced a $95 million (US $70 million) […]
ZAGENO Empowers Life Science Research with Unparalleled Efficiency and Cost Savings CAMBRIDGE, Mass. – ZAGENO, the leading online marketplace for life science research products, announces the completion of a $33 million funding round. General Catalyst, the largest public pension fund in the United States, Grazia Equity, OakRidge Management Group, and a German investment house led […]
Deal Enhances Development and Discovery in Energy, Batteries, Mining and Advanced Manufacturing TULSA, Okla. — EIC Rose Rock, an early-stage VC fund focused on energy technologies, today announced its direct investment into Exum Instruments, a Denver-based scientific instrumentation company with innovative technology that significantly shortens development and discovery to provide full characterization of solid materials […]
TULSA, Okla. — FortySix Venture Capital LLC, (46VC), a Tulsa -based venture capital firm, is excited to announce its strategic investment in Exum Instruments’ Series A funding round, marking the first investment from their recently launched Kinetic Fund. Exum Instruments, a Denver -based scientific instruments company, has developed the revolutionary Massbox ™ , a cutting-edge instrument that democratizes mass spectrometry analysis. Unlike […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
